News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2018 Shelley Wood November 30, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News ESC 2018 GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI Michael O'Riordan August 27, 2018
News Conference News ESC 2018 Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE Shelley Wood August 26, 2018
News Daily News In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check Caitlin E. Cox August 15, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
News Conference News EAS 2018 Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention Yael L. Maxwell May 07, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018
News Conference News ACC 2018 Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension Michael O'Riordan March 15, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018